Compare GNLX & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | TRX |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 228.9M |
| IPO Year | 2023 | N/A |
| Metric | GNLX | TRX |
|---|---|---|
| Price | $4.73 | $0.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $19.75 | $1.25 |
| AVG Volume (30 Days) | 313.6K | ★ 1.0M |
| Earning Date | 11-05-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $57,613,000.00 |
| Revenue This Year | N/A | $28.16 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $303.35 |
| Revenue Growth | N/A | ★ 39.98 |
| 52 Week Low | $1.99 | $0.27 |
| 52 Week High | $8.54 | $0.85 |
| Indicator | GNLX | TRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 57.86 |
| Support Level | $4.54 | $0.60 |
| Resistance Level | $5.89 | $0.75 |
| Average True Range (ATR) | 0.54 | 0.05 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 11.05 | 81.00 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.